Maryam Tavafoghi

Maryam Tavafoghi

Auto-generated profile, based on publicly available information

Maryam Tavafoghi

Department of Bioengineering, University of California, Los Angeles, 410 Westwood Plaza, Los Angeles, CA 90095, USA

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 October 2016 in Journal of The Royal Society Interface
Verified
Journal Article
Open access
MTM. Tavafoghi
M. Tavafoghi
MCM. Cerruti
M. Cerruti
Polar and charged amino acids (AAs) are heavily expressed in non-collagenous proteins (NCPs), and are involved in hydroxyapatite (HA) mineralization in bone. Here, we review what is known on the effect of single AAs on HA precipitation. Negatively charged AAs, such as aspartic acid, glutamic acid (Glu) and phosphoserine are largely expressed in NCPs and play a critical role in controlling HA nucleation and growth. Positively charged ones such as arginine (Arg) or lysine (Lys) are heavily involved in HA nucleation within extracellular matrix proteins such as collagen. Glu, Arg and Lys intake can also increase bone mineral density by stimulating growth hormone production. In vitro studies suggest that the role of AAs in controlling HA precipitation is affected by their mobility. While dissolved AAs are able to inhibit HA precipitation and growth by chelating Ca2+ and PO43− ions or binding to nuclei of calcium phosphate and preventing their further growth, AAs bound to surfaces can promote HA precipitation by attracting Ca2+ and PO43− ions and increasing the local supersaturation. Overall, the effect of AAs on HA precipitation is worth being investigated more, especially under conditions closer to the physiological ones, where the presence of other factors such as collagen, mineralization inhibitors, and cells heavily influences HA precipitation. A deeper understanding of the role of AAs in HA mineralization will increase our fundamental knowledge related to bone formation, and could lead to new therapies to improve bone regeneration in damaged tissues or cure pathological diseases caused by excessive mineralization in tissues such as cartilage, blood vessels and cardiac valves.

5 August 2021 in Biofabrication
Verified
Journal Article
Closed access
PDF file
MTMaryam Tavafoghi
Maryam Tavafoghi
MDMohammad Ali Darabi
Mohammad Ali Darabi
MMMahboobeh Mahmoodi
Mahboobeh Mahmoodi
RTRumeysa Tutar
Rumeysa Tutar
Chun XuChun Xu
Chun Xu
Nureddin AshammakhiNureddin Ashammakhi
Nureddin Ashammakhi
Tissue reconstruction requires the utilization of multiple biomaterials and cell types to replicate the delicate and complex structure of native tissues. Various three-dimensional (3D) bioprinting techniques have been developed to fabricate customized tissue structures; however, there are still significant challenges, such as vascularization, mechanical stability of printed constructs, and fabrication of gradient structures to be addressed for the creation of biomimetic and complex tissue constructs. One approach to address these challenges is to develop multimaterial 3D bioprinting techniques that can integrate various types of biomaterials and bioprinting capabilities towards the fabrication of more complex structures. Notable examples include multi-nozzle, coaxial, and microfluidics-assisted multimaterial 3D bioprinting techniques. More advanced multimaterial 3D printing techniques are emerging, and new areas in this niche technology are rapidly evolving. In this review, we briefly introduce the basics of individual 3D bioprinting techniques and then discuss the multimaterial 3D printing techniques that can be developed based on combination of these techniques for the engineering of complex and biomimetic tissue constructs. We also discuss the perspectives and future directions to develop state-of-the-art multimaterial 3D bioprinting techniques for engineering tissues and organs.

23 February 2023 in Molecules
Verified
Journal Article
Open access
PDF file
MHMuhammad Haris
Muhammad Haris
NFNamra Fatima
Namra Fatima
JIJaved Iqbal
Javed Iqbal
WCWadie Chalgham
Wadie Chalgham
AMAbdul Samad Mumtaz
Abdul Samad Mumtaz
MTMaryam Tavafoghi
Maryam Tavafoghi
Iron oxide nanoparticles (Fe2O3-NPs) were synthesized using Oscillatoria limnetica extract as strong reducing and capping agents. The synthesized iron oxide nanoparticles IONPs were characterized by UV-visible spectroscopy, Fourier transform infrared (FTIR), X-ray diffractive analysis (XRD), scanning electron microscope (SEM), and Energy dispersive X-ray spectroscopy (EDX). IONPs synthesis was confirmed by UV-visible spectroscopy by observing the peak at 471 nm. Furthermore, different in vitro biological assays, which showed important therapeutic potentials, were performed. Antimicrobial assay of biosynthesized IONPs was performed against four different Gram-positive and Gram-negative bacterial strains. E. coli was found to be the least suspected strain (MIC: 35 µg/mL), and B. subtilis was found to be the most suspected strain (MIC: 14 µg/mL). The maximum antifungal assay was observed for Aspergillus versicolor (MIC: 27 µg mL). The cytotoxic assay of IONPs was also studied using a brine shrimp cytotoxicity assay, and LD50 value was reported as 47 µg/mL. In toxicological evaluation, IONPs was found to be biologically compatible to human RBCs (IC50: >200 µg/mL). The antioxidant assay, DPPH 2,2-diphenyl-1-picrylhydrazyly was recorded at 73% for IONPs. In conclusion, IONPs revealed great biological potential and can be further recommended for in vitro and in vivo therapeutic purposes.

16 July 2021 in Materials Chemistry Frontiers
Verified
Journal Article
Closed access
PDF file
SDSibel Emir Diltemiz
Sibel Emir Diltemiz
MTMaryam Tavafoghi
Maryam Tavafoghi
NBNatan Roberto de Barros
Natan Roberto de Barros
MKMasamitsu Kanada
Masamitsu Kanada
Jyrki HeinämäkiJyrki Heinämäki
Jyrki Heinämäki
Nureddin AshammakhiNureddin Ashammakhi
Nureddin Ashammakhi
Cells are the fundamental functional units of biological systems and mimicking their size, function and complexity is a primary goal in the development of new therapeutic strategies.

5 August 2022 in Biotechnology and Bioengineering
Verified
Journal Article
Closed access
MTMaryam Tavafoghi
Maryam Tavafoghi
FNFatemeh Nasrollahi
Fatemeh Nasrollahi
SKSolmaz Karamikamkar
Solmaz Karamikamkar
MMMahboobeh Mahmoodi
Mahboobeh Mahmoodi
SNSara Nadine
Sara Nadine
Ali  KhademhosseiniAli Khademhosseini
Ali Khademhosseini

1 December 2021 in Artificial Organs
Verified
Journal Article
Closed access
PDF file
MTMaryam Tavafoghi
Maryam Tavafoghi
Ali  KhademhosseiniAli Khademhosseini
Ali Khademhosseini
Samad AhadianSamad Ahadian
Samad Ahadian